Embedded Files
Conference presentation (Abstract):
Conference presentation (Abstract):
1. Victor Tatarskii, Wai-kin Chan, Lin Tan, Alvina Khamidullina, Mahmud I. The asns inhibitor asx-173 potentiates l-asparaginase anticancer activity. Blood, Volume 146, Supplement 1, 3 November 2025, Page 4327
1. Victor Tatarskii, Wai-kin Chan, Lin Tan, Alvina Khamidullina, Mahmud I. The asns inhibitor asx-173 potentiates l-asparaginase anticancer activity. Blood, Volume 146, Supplement 1, 3 November 2025, Page 4327
2. Koral Richard, Alia Ghrayeb, mary McKinney, Alexandra Finney, Sumit Anand, Sumati Rohilla, Sandeep Das, Fabio Arias Bordajandi, Brenna Pearson-Gallion, Bo Wei, Mahmud I, Lin Tan, Wayne Orr, Arif Yurdagul, Inbal Mor, Philip Lorenzi, Eyal Gottlieb, Oren Rom. Hepatic Serine Hydroxymethyltransferase 2 Drives Atherosclerosis through One-Carbon Metabolic Regulation of VLDL and Ceramides. Arteriosclerosis, Thrombosis, and Vascular Biology, 2025, Volume 45, Number Suppl_1, https://doi.org/10.1161/atv.45.suppl_1.Or119.
2. Koral Richard, Alia Ghrayeb, mary McKinney, Alexandra Finney, Sumit Anand, Sumati Rohilla, Sandeep Das, Fabio Arias Bordajandi, Brenna Pearson-Gallion, Bo Wei, Mahmud I, Lin Tan, Wayne Orr, Arif Yurdagul, Inbal Mor, Philip Lorenzi, Eyal Gottlieb, Oren Rom. Hepatic Serine Hydroxymethyltransferase 2 Drives Atherosclerosis through One-Carbon Metabolic Regulation of VLDL and Ceramides. Arteriosclerosis, Thrombosis, and Vascular Biology, 2025, Volume 45, Number Suppl_1, https://doi.org/10.1161/atv.45.suppl_1.Or119.
3. Sandeep Das, SUMIT ANAND, mary McKinney, Mahmud I, Sumati Rohilla, Koral Richard, Fabio Arias Bordajandi, Alia Ghrayeb, Bo Wei, Lin Tan, zhipeng liu, Dhananjay kumar, Nilesh Pandey, Harpreet Kaur, Babak Razani, Bishuang Cai, Wanqing Liu, Edward Fisher, Sridhar Radhakrishnan, Eyal Gottlieb, Wayne Orr, Nirav Dhanesha, Arif Yurdagul, Philip Lorenzi, Oren Rom. Modeling Concurrent Metabolic Dysfunction-Associated Steatohepatitis and Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 2025, Volume 45, Number Suppl_1, https://doi.org/10.1161/atv.45.suppl_1.Tu0043.
3. Sandeep Das, SUMIT ANAND, mary McKinney, Mahmud I, Sumati Rohilla, Koral Richard, Fabio Arias Bordajandi, Alia Ghrayeb, Bo Wei, Lin Tan, zhipeng liu, Dhananjay kumar, Nilesh Pandey, Harpreet Kaur, Babak Razani, Bishuang Cai, Wanqing Liu, Edward Fisher, Sridhar Radhakrishnan, Eyal Gottlieb, Wayne Orr, Nirav Dhanesha, Arif Yurdagul, Philip Lorenzi, Oren Rom. Modeling Concurrent Metabolic Dysfunction-Associated Steatohepatitis and Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 2025, Volume 45, Number Suppl_1, https://doi.org/10.1161/atv.45.suppl_1.Tu0043.
4. Angela Casaril, Caitlyn Gaffney, Mahmud I, Bo Wei, Lei Shi, Theresa Guise, Phillip Lorenzi, Carolyn Hodo, Andrew Shepherd. Inflammatory Neuropathy in Mouse Models of Colorectal Cancer: Implications for Chemotherapy-Induced Peripheral Neuropathy. The Journal of pain, Volume 9, Supplement 104941, April 2025.
4. Angela Casaril, Caitlyn Gaffney, Mahmud I, Bo Wei, Lei Shi, Theresa Guise, Phillip Lorenzi, Carolyn Hodo, Andrew Shepherd. Inflammatory Neuropathy in Mouse Models of Colorectal Cancer: Implications for Chemotherapy-Induced Peripheral Neuropathy. The Journal of pain, Volume 9, Supplement 104941, April 2025.
5. Aaron Schwartz-Duval, Yuri Mackeyev, Mahmud I, Philip L. Lorenzi, Mihai Gagea, Sunil Krishnan, Konstantin V. Sokolov. Proceedings Volume PC13336, Colloidal Nanoparticles for Biomedical Applications XX; PC133360F (2025) https://doi.org/10.1117/12.3043322.
5. Aaron Schwartz-Duval, Yuri Mackeyev, Mahmud I, Philip L. Lorenzi, Mihai Gagea, Sunil Krishnan, Konstantin V. Sokolov. Proceedings Volume PC13336, Colloidal Nanoparticles for Biomedical Applications XX; PC133360F (2025) https://doi.org/10.1117/12.3043322.
6. Feiyu Chen, Haoyan Li, Yin Wang, Ximing Tang, Kevin Lin, Qidong Li, Chenling Meng, Wei Shi, Javier Leo, Xin Liang, Jie Zhang, Vivien Van, Mahmud I, Bo Wei, Philip L. Lorenzi, Maria G. Raso, Ana Aparicio, Yue Lu, Daniel E. Frigo, Boyi Gan, Di Zhao. CHD1 loss hijacks SREBP2-mediated cholesterol biosynthesis to fuel SPOP-deficient prostate cancer and confers resistance to castration. Cancer Res 2025;85(8_Suppl_1):Abstract nr 6367.
6. Feiyu Chen, Haoyan Li, Yin Wang, Ximing Tang, Kevin Lin, Qidong Li, Chenling Meng, Wei Shi, Javier Leo, Xin Liang, Jie Zhang, Vivien Van, Mahmud I, Bo Wei, Philip L. Lorenzi, Maria G. Raso, Ana Aparicio, Yue Lu, Daniel E. Frigo, Boyi Gan, Di Zhao. CHD1 loss hijacks SREBP2-mediated cholesterol biosynthesis to fuel SPOP-deficient prostate cancer and confers resistance to castration. Cancer Res 2025;85(8_Suppl_1):Abstract nr 6367.
7. Nazli Dizman1, Mahmud I2, Julie Simon3, Elizabeth Sirmans4, Hussein A. Tawbi4, Jeffrey E. Gershenwald3, Michael Davies4, Nadim Ajami5, Carrie Daniel-MacDougall6, Jennifer Wargo3, Philip Lorenzi2, Jennifer McQuade4. Circulating metabolites associated with response to immune checkpoint blockade in melanoma. Cancer Res, American Association for cancer research (AACR) Annual Meeting, April 25-30, 2025.
7. Nazli Dizman1, Mahmud I2, Julie Simon3, Elizabeth Sirmans4, Hussein A. Tawbi4, Jeffrey E. Gershenwald3, Michael Davies4, Nadim Ajami5, Carrie Daniel-MacDougall6, Jennifer Wargo3, Philip Lorenzi2, Jennifer McQuade4. Circulating metabolites associated with response to immune checkpoint blockade in melanoma. Cancer Res, American Association for cancer research (AACR) Annual Meeting, April 25-30, 2025.
8. Swetha Kumar, Mahmud I, Hasan MM, Ahmed K, Lorenzi P, Hoffman KL, and Carrie M. Microbiome-derived indole metabolites and response to immune checkpoint inhibitors in patients with hepatocellular carcinoma. Cancer Res, American Association for cancer research (AACR) Annual Meeting, April 25-30, 2025.
8. Swetha Kumar, Mahmud I, Hasan MM, Ahmed K, Lorenzi P, Hoffman KL, and Carrie M. Microbiome-derived indole metabolites and response to immune checkpoint inhibitors in patients with hepatocellular carcinoma. Cancer Res, American Association for cancer research (AACR) Annual Meeting, April 25-30, 2025.
9. Mahmud I, Wai-kin Chan, Karen Yannell2, Cate Simmermaker2, Genevieve Van de Bittner2, Linfeng Wu2, Sheher Moshin2, Yiwei Liu1, John Sausen2, and Philip L. Lorenzi. A multi-omic mass spectrometry for elucidation of the mechanisms of drug toxicity. 13th Metabolism symposium, MD Anderson Cancer Center, September 19th, 2024.
9. Mahmud I, Wai-kin Chan, Karen Yannell2, Cate Simmermaker2, Genevieve Van de Bittner2, Linfeng Wu2, Sheher Moshin2, Yiwei Liu1, John Sausen2, and Philip L. Lorenzi. A multi-omic mass spectrometry for elucidation of the mechanisms of drug toxicity. 13th Metabolism symposium, MD Anderson Cancer Center, September 19th, 2024.
10. Nicholas Blazanin, Xiaobing Liang, Mahmud I, Eiru Kim, Lin Tan, Nazanin Esmaeili Anvar, Waikin Chan, Min Jin Ha, Rosalba Minelli, Michael Peoples, Philip Lorenzi, Travar Hart, Yonathan Lissanu. Therapeutic modulation of rock overcomes metabolic adaption to oxphos inhibition and suppresses tumor growth. Cancer Res (2024) 84 (6_Supplement): 5972. https://doi.org/10.1158/1538-7445.AM2024-5972).
10. Nicholas Blazanin, Xiaobing Liang, Mahmud I, Eiru Kim, Lin Tan, Nazanin Esmaeili Anvar, Waikin Chan, Min Jin Ha, Rosalba Minelli, Michael Peoples, Philip Lorenzi, Travar Hart, Yonathan Lissanu. Therapeutic modulation of rock overcomes metabolic adaption to oxphos inhibition and suppresses tumor growth. Cancer Res (2024) 84 (6_Supplement): 5972. https://doi.org/10.1158/1538-7445.AM2024-5972).
11. Hissah Alatawi, Nayeong Koo, Mahmud I, Haritha Nair, Amandeep Singh, Timothy J Garrett, Arun K Sharma, Sukwon Hong, Satya Narayan. A novel ceramide synthase 2 agonist and its implication in triple-negative breast cancer therapy. Cancer Res (2024) 84 (6_Supplement): 4692. https://doi.org/10.1158/1538-7445.AM2024-4692.
11. Hissah Alatawi, Nayeong Koo, Mahmud I, Haritha Nair, Amandeep Singh, Timothy J Garrett, Arun K Sharma, Sukwon Hong, Satya Narayan. A novel ceramide synthase 2 agonist and its implication in triple-negative breast cancer therapy. Cancer Res (2024) 84 (6_Supplement): 4692. https://doi.org/10.1158/1538-7445.AM2024-4692.
12. Caleb Shi, Mahmud I, P Jacqueline, TO Findley. Transcriptomic and metabolomic profiling reveal sex-related differences in cyanotic congenital heart defects. The American Journal of the Medical Sciences, 2024.
12. Caleb Shi, Mahmud I, P Jacqueline, TO Findley. Transcriptomic and metabolomic profiling reveal sex-related differences in cyanotic congenital heart defects. The American Journal of the Medical Sciences, 2024.
13. Mahmud I and Philip L. Lorenzi. Lipid Biochemistry in Cancer. 34th Fall workshop on mass spectrometry on Lipidomics: The essentials to the cutting edge. November 6-7, 2023, New Orleans, LA.
13. Mahmud I and Philip L. Lorenzi. Lipid Biochemistry in Cancer. 34th Fall workshop on mass spectrometry on Lipidomics: The essentials to the cutting edge. November 6-7, 2023, New Orleans, LA.
14. Mahmud I*, Anika Patel, Lin Tan, Sara Martinez, Bao Tran, Bo Wei, Rehan Akbani, Bradley Broom, John N. Weinstein, and Philip L. Lorenzi*. Noise Filtering in Non-targeted Metabolomics. 72nd ASMS conference on Mass Spectrometry and Allied Topics, June 4-8, Houston, TX (2023). (Poster).
14. Mahmud I*, Anika Patel, Lin Tan, Sara Martinez, Bao Tran, Bo Wei, Rehan Akbani, Bradley Broom, John N. Weinstein, and Philip L. Lorenzi*. Noise Filtering in Non-targeted Metabolomics. 72nd ASMS conference on Mass Spectrometry and Allied Topics, June 4-8, Houston, TX (2023). (Poster).
15. Mahmud I. Metabolomic technologies in deciphering altered metabolism in human disease. July 20th 2022, The Brown foundation, Institute of Molecular Medicine for the prevention of human disease, McGovern Medical school, UT Health, Houston TX. (Invited talk).
15. Mahmud I. Metabolomic technologies in deciphering altered metabolism in human disease. July 20th 2022, The Brown foundation, Institute of Molecular Medicine for the prevention of human disease, McGovern Medical school, UT Health, Houston TX. (Invited talk).
15. Mahmud I. Metabolomics approaches to interpret altered cancer metabolism and therapeutic vulnerabilities. October 13th 2022, Department of Melanoma Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston TX. (Invited talk).
16. Mahmud I, Mamun Kabir, Rashidul Haque, Timothy J. Garrett. FAHFA (Fatty acid esters of hydroxy fatty acids) globally reduced in malnourished children and impart therapy development. 69th ASMS conference on mass spectrometry and allied topics. October 31 – November 4, 2021, Philadelphia, PA. (Oral)
17. Mahmud I and Timothy J Garrett. Global plasma metabolic landscape of malnourished children. 3rd Annual Metabolomics Association of North America (MANA) conference, October 18-21, 2021. (Oral)
18. Mahmud I, Paul Crispen, Timothy J. Garrett. Urinary metabolite-based diagnosis of prostate malignancy. 85th Annual meeting of the Southeastern Section of the American Urology Association (SESAUA), April 23-24, 2021. (Oral)
19. Mahmud I, Timothy J. Garrett. Urinary metabolite-based diagnosis of prostate malignancy. Southeast regional clinical and translational science conference – Georgia CTSA, March 4-5, 2021. (Oral)
20. Mahmud I, Rhoel Dinglasan, Timothy J. Garrett. High Resolution Mass Spectrometry-based multiomics delineates rapid detection of malaria, Zika, Dengue, and coronavirus. IV Florida Malaria Consortium Meeting (vM4), March 12, 2021. (Oral)
21. Mahmud I, Paul Crispen, Timothy J. Garrett. Urinary metabolite-based diagnosis of prostate malignancy and surveillance. UF Health Cancer Center (UFHCC) virtual research symposium, December 8-10, 2020. (Poster)
22. Mahmud I, Narayan S, Garrett TJ (2020). Identifying metabolic dark matter (unknown) with therapeutic potential in tumor suppressor deficient colorectal cancer cells. American Association for cancer research (AACR) Annual Meeting, June 22-24, 2020.
23. Mahmud I and Timothy J. Garrett. Cancer metabolic rewiring in host-microbiota interface. 68th ASMS conference on mass spectrometry and allied topics. ASMS 2020 Reboot.
24. Mahmud I, Sasanka Sekhar Chukkapalli, Ann Progulske-Fox, Timothy J. Garrett. A Landscape of Fusobacterium-Modulated Metabolism in Oral Cancer. 32nd Sanibel conference on mass spectrometry. January 23-29, 2020, South Seas Island Resort, Captiva, FL.
25. Mahmud I, Harmon T. Garrett T.J. An Arsenal of Metabolic Peak Picking and Statistical Tools for biomarker identification. University of Florida Informatics Institute Annual Research Symposium, October 2019.
26. Mahmud I, Kabir M, Haque R, Garrett T.J. Precision Therapy Development for Child Malnutrition Through Multi-omics Technologies. Research day: CTSI MD-PhD program. University of Florida, 29th May, 2019.
27. Mahmud I, Lee B, Perera R, Garrett TJ. Multi-omics Approaches Reveal Potential Role for Corticosterone in Prostate Cancer. American Association for cancer Research (AACR) Annual Meeting, Atlanta, Georgia, March 29th – April 3rd. (April 2019).
28. Mahmud I, Tian G, Wang J, Stowe R, Zhang Y, Purayil HT, Helm E, Drashansky T, Avram D, Daaka Y, Roush WR, Liao D (2019). SR-4370, a potent and selective inhibitor of class I HDACs, suppresses AR signaling and in vivo prostate tumor growth. American Association for cancer Research (AACR) Annual Meeting, Atlanta, Georgia, March 29th – April 3rd. (April 2019).
29. Mahmud I, Cagmat J. G., Meke L. E. , Quinlivan E.P., Garrett T.J. Principles of Global Metabolomics Towards The Development of Precision Medicine. Celebration of Research, UF College of Medicine (COM), February 19th (2019).
30. Mahmud I, Garrett TJ, Stowe R, Roush W, Liao D. Chemically distinct class I HDAC inhibitors synergize to inhibit global lipid metabolism in cancer. American Association for cancer Research (AACR) Annual Meeting, Chicago, Illinois, April 14th – 18th (2018).
31. Mahmud I, Timothy J. Garrett, Daiqing Liao. DAXX promotes de novo lipogenesis in triple-negative breast cancer. UF Health Cancer Center (UFHCC) research day (November, 2018). (Poster)
32. Mahmud I, Garrett TJ, Liao D. DAXX promotes de novo lipogenesis in triple-negative breast cancer. Celebration of Research, UF College of Medicine (COM), February 19th (2018). (Poster)
33. Mahmud I, Garrett TJ, Liao D. Death Domain Associated Protein (DAXX) regulates a distinct lipid metabolism signature in breast cancer. Celebration of Research, UF College of Medicine (COM), February 27nd (2017). (Poster)
34. Mahmud I, Garrett TJ, Liao D. Potential regulation of polyamine metabolism in breast cancer by death domain associated protein DAXX. Celebration of Research, UF College of Medicine (COM), February 22nd (2016). (Poster)
35. Mahmud I, Timothy J. Garrett, Daiqing Liao. Death Domain Associated Protein DAXX May Regulate a Distinct Lipid Metabolism Signature in Breast Cancer. 64th ASMS conference on Mass Spectrometry and Allied Topics, June 5-9, San Antonio, TX (2016). (Poster)
36. Mahmud I, Timothy J. Garrett, Daiqing Liao. Role of DAXX in Breast cancer metabolism. Clinical & Pharmaceutical Solutions through Analysis (CPSA Metabolomics Symposium), Gainesville, FL, March 21-23 (2016). (Poster)
37. Mahmud I, Timothy J. Garrett, Daiqing Liao. DAXX regulates lipid metabolism in breast cancer. Celebration of Research, UF College of Medicine (COM), February 22nd (2016). (Poster)
38. Mahmud I, Chandrasehar Kousik, Kamal Chowdhury, Arezue Boroujerdi. Identification of metabolite translocation between disease resistance rootstocks to susceptible watermelon scion. Experimental Nuclear Magnetic Resonance (ENC) conference, Boston, March 22-28 (2014). (Poster)
39. Mahmud I, Arezue Boroujerdi, Kamal Chowdhury. NMR-based Metabolic profile in sugarcane. ACS Chemical society South Carolina Chapter, Claflin University, SC, April 2014. (Poster)
40. Mahmud I, Monica Thapaliya, Arezue Boroujerdi, Kamal Chowdhury. NMR-based metabolomics study of the biochemical relationship between sugarcane callus tissues and their respective nutrient culture media. SERMACS (Southeastern Regional Meeting of American Chemical Society), Atlanta, November 12-16, GA, USA (2013). (Poster)
41. Mahmud I, Bhawana Shrestha, Arezue Boroujerdi, Kamal Chowdhury. NMR-basedMetabolomics Profile Comparison to Distinguish between Embryogenic and Non-Embryogenic Callus Tissue of Sugarcane at the Biochemical Level. SERMACS (Southeastern Regional Meeting of American Chemical Society), Atlanta, November 12-16, GA, USA (2013). (Poster)
42. Mahmud I, Kamal Chowdhury, Arezue Boroujerdi. NMR-based metabolomics reveal metabolites associated with powdery mildew disease resistant in watermelon. SERMACS (Southeastern Regional Meeting of American Chemical Society), Atlanta, November 12-16, GA, USA (2013). (Oral and Poster)
43. Mahmud I, Chandrasehar Kousik, Richard Hassell, Kamal Chowdhury, Arezue Boroujerdi. NMR Spectroscopy Identifies Metabolites Translocated from Powdery Mildew Resistant Rootstocks to Susceptible Watermelon Scions. UNC Charlotte Life Sciences Conference, October 24th, NC (2013). (Poster)
Page updated
Google Sites
Report abuse